开发一种可解释的机器学习模型,用于使用临床和行为特征来预测阿尔茨海默病
Rajkumar Govindarajan1, K Thirunadanasikamani1, Komal Kumar Napa2
1Department of Computer Science and Engineering, St. Peter's Institute of Higher Education and Research, Avadi, Chennai, India.
MethodsX
|July 23, 2025
概括
这项研究使用临床数据开发了一种用于早期阿尔茨海默病 (AD) 预测的机器学习模型,达到93.9%的准确性. 该模型提供可解释的见解和一个用户友好的网络应用程序,用于临床决策支持.
科学领域:
- 计算神经科学是一种计算神经科学.
- 医疗信息学医学信息学
- 机器学习在医疗保健中的应用
背景情况:
- 早期发现阿尔茨海默病 (AD) 对于及时干预至关重要.
- 现有的诊断方法可能具有侵入性或缺乏预测能力.
- 机器学习为数据驱动的早期AD预测提供了潜力.
研究的目的:
- 为早期预测阿尔茨海默病提供可复制的机器学习方法.
- 为了提高模型的可解释性,用于临床应用.
- 为临床医生和研究人员开发一个用户友好的工具.
主要方法:
- 利用临床和行为数据进行预测建模.
- 对比了多个分类算法,包括梯度提升.
- 集成的SHapley添加式解释 (SHAP) 进行特征解释.
- 使用Streamlit. developed开发了一个交互式Web应用程序.
主要成果:
- 梯度提升分类器实现了高性能 (93.9%的准确性,91.8%的F1分数).
- SHAP分析确定了关键的预测变量:MMSE,ADL,胆固醇和功能评分.
- SHAP值提供了全球和个体特征贡献的洞察力.
- 流明应用程序实现了实时,可解释的预测.
结论:
- 开发的方法提供了早期AD诊断和风险评估的实用工具.
- 可解释的人工智能 (SHAP) 增强了临床信任和对预测因素的理解.
- 交互式网络应用程序促进了知情的临床决策和个性化的患者护理.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.3K
相关概念视频
01:26Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
01:22Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
01:30Dementia
167
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
167